JM Sante Pharma
JM Sante Pharma is a Polish veterinary pharmaceutical manufacturer and DTC e-commerce operator selling eight branded product lines (wound care, dermatology, oral/digestive care, natural cosmetics, supplements, diagnostics) for dogs and cats across Poland and select export markets.
- Company typePrivate
- Founded-
- HeadquartersSosnowiec, Poland
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What JM Sante Pharma does
JM Sante Pharma is a privately held Polish veterinary pharmaceutical company operating as JM SANTE PHARMA Sp. z o.o. (KRS 0000912373) from its registered office at ul. Krzysztofa Kamila Baczyńskiego 25A, Sosnowiec, with a stated 150,000 PLN share capital and approximately 20 employees. The company develops and markets a portfolio of specialty products for companion animals (dogs and cats) organized across eight registered trademarked lines: POLISEPT VET for wound care (hydrocolloid gels, irrigation solutions, antiseptic sprays using Polyhexanid/PHMB and Betain), POLIDERM for sensitive skin and coat, VET PROTECTOR for oral and digestive care, GREEN SANTE for natural cosmetics, MULTIWAY VET for joint/coat/kidney/stress supplements in twist-off DUOCAPS form, MONOVET POWER and DOG POWER SHOT for energy and fitness, and JM SANTE DIAGNOSTIC for professional rapid diagnostic tests.
The underlying technology is formulation-driven rather than software-driven: active-ingredient combinations (PHMB/Betain for antimicrobial wound management and biofilm disruption; natural/eco-friendly ingredients for the GREEN SANTE line), packaging innovation (RPET and aluminum), and a DUOCAPS twist-off capsule delivery system. Manufacturing follows GMP standards per the company's product claims, and formulations are positioned as developed with veterinary and phytotherapy experts.
JM Sante Pharma's commercial model is anchored on direct-to-consumer e-commerce via the multilingual jmsante.pl storefront (Polish, English, German, Czech), where products are sold at unit prices ranging from 8.50 to 129.90 PLN with a 50 PLN free-shipping threshold and loyalty rewards at 100 PLN and 299 PLN. A secondary B2B/export channel targets European veterinary clinics, distributors, and partners via a dedicated export contact and international product catalogs, though domestic delivery is currently limited to Poland. Customer segments split between individual pet owners seeking OTC-grade veterinary products and veterinary professionals requiring clinical wound-care and diagnostic supplies. Marketing is executed through the e-commerce site, organic social (Facebook, Instagram, YouTube), email newsletter, and an educational Knowledge Base covering pet health topics.
JM Sante Pharma firmographics
Firmographics- Name
- JM Sante Pharma
- Legal name
- JM SANTE PHARMA Sp. z o.o.
- Website
- https://jmsante.pl
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- JM Sante Pharma is a Polish veterinary pharmaceutical manufacturer and DTC e-commerce operator selling eight branded product lines (wound care, dermatology, oral/digestive care, natural cosmetics, supplements, diagnostics) for dogs and cats across Poland and select export markets.
- Ownership category
- akta.pro rank
JM Sante Pharma industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pet and Pet Supplies Retailers (459910), Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)
- akta.pro secondary industries
- Compounding Pharmacies (Veterinary) (HLAMAIAD), Animal Health OTC Retail (Parasite Control, Basic Care) (HLAMAIAJ), Veterinary Pharmacy, Vaccine & Biologics Services (AFAEANAK)
Keywords
Where JM Sante Pharma is headquartered
LocationHeadquarters
- HQ city
- Sosnowiec
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
JM Sante Pharma business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D
Revenue model
- Direct E-commerce Sales: The company operates an online store selling veterinary pharmaceutical products directly to pet owners. Products are sold at individual unit prices with free shipping thresholds. Revenue is generated through one-time product purchases across multiple categories including wound care, skincare, supplements, and accessories.
- B2B/Export Sales: The company exports products internationally through B2B channels, with dedicated export email contact ([email protected]) and international product catalogs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual product pricing ranging from 8.50 PLN to 129.90 PLN |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
JM Sante Pharma product offering
Product offeringCore offering
JM Sante Pharma develops, manufactures, and sells a portfolio of veterinary pharmaceutical and care products for companion animals (dogs and cats) under multiple branded product lines. Offerings include wound care products (hydrocolloid gels, irrigation solutions, antiseptic sprays), skin and coat care (shampoos, emulsions, balms), oral cavity care, joint/kidney/digestive supplements, and natural cosmetic care products. Products are sold primarily through the company's own direct-to-consumer e-commerce store (jmsante.pl) in Poland, with secondary B2B/export distribution to international markets.
Product overview
JM Sante Pharma is a Polish veterinary pharmaceutical company offering a comprehensive portfolio of specialized products for companion animals (dogs and cats). The company operates multiple product lines: POLISEPT VET® provides wound care products (hydrocolloid gels, irrigation solutions, antiseptic sprays); POLIDERM® offers skin and coat care solutions; VET PROTECTOR® supports oral cavity and digestive health; GREEN SANTE® delivers natural cosmetic care products; MULTIWAY VET® provides supplement capsules for joints, coat, kidneys, and stress relief; MONOVET POWER® offers products with transparent composition; DOG POWER SHOT® targets physical fitness; and JM SANTE DIAGNOSTIC® provides professional diagnostic quick tests. The products are manufactured according to GMP standards and distributed primarily within Poland.
Differentiator
Problem solved
Functional benefit
Brands
- VET PROTECTOR®: Product line for treatment and prevention of animal diseases
- POLISEPT VET®
- GREEN SANTE®
- POLIDERM®
- MULTIWAY VET®
- MONOVET POWER®
- DOG POWER SHOT®
- JM SANTE DIAGNOSTIC®
Companies that use JM Sante Pharma
Customer profileNamed customers3 records
Segments2 records
Ideal customer profiles2 records
JM Sante Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
JM Sante Pharma partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Veterinarians and Veterinary Clinics (European)coreJM Sante Pharma positions itself as supporting veterinarians across Europe. The company provides specialized veterinary products that assist veterinarians in their practice and contribute to the welfare of companion animals. The partnership is described as supporting veterinary professionals in treatment and prevention of animal diseases.
- European Pet Retailers and DistributorsminorThe company appears to have distribution partnerships for its products across Europe. The [email protected] contact suggests international distribution relationships. The company mentions supporting animal welfare across the continent.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
JM Sante Pharma competitors and assessment
Company assessmentDirect peers
- Virbac: France-based global veterinary pharmaceutical company offering companion-animal therapeutics, dermatology, wound care and supplements. Directly comparable as a multi-species, multi-category veterinary pharma with overlapping wound and dermatology product lines.
- Ceva Santé Animale: Global veterinary pharmaceutical company headquartered in France with substantial companion-animal exposure in dermatology, anti-infectives and supplements. Directly competes in wound management and specialty therapeutics for dogs and cats.
- Calier (Grupo Indukern): Spanish veterinary pharmaceutical manufacturer offering companion-animal therapeutics, dermatology and nutraceuticals in European and emerging markets — a comparable mid-size European vet pharma peer.
- Vetoquinol: Independent French veterinary pharmaceutical group focused on companion animals and livestock, with strong portfolios in dermatology, wound care and supplements — closely mirroring JM Sante's mix of POLIDERM, POLISEPT VET and MULTIWAY VET.
- Dechra Pharmaceuticals: UK-listed (now part of Elanco) veterinary pharma specialist with companion-animal focus across endocrinology, dermatology and anti-infectives. Comparable niche/specialty pharma positioning to JM Sante.
Regional players
- Veto-Pharma (Hungary): Central European veterinary pharmaceutical manufacturer specializing in parasiticides, dermatology and specialty therapeutics for companion animals. Comparable as a CEE-based regional vet pharma peer.
- ScanVet (Poland): Poland-based veterinary pharmaceutical company producing a range of veterinary medicines, supplements and care products for companion animals and livestock. Most direct geographic peer for JM Sante in the Polish market.
Broad incumbents
- Elanco Animal Health: Global animal health leader following its acquisition of Bayer Animal Health and Dechra. Overlaps JM Sante's dermatology, anti-infective and supplement categories at much larger scale.
- Zoetis: World's largest animal health company with broad companion-animal portfolios in dermatology, parasiticides and diagnostics. Represents the broad incumbent competing across most of JM Sante's categories at much greater scale.
- Boehringer Ingelheim Animal Health: Major animal health division of Boehringer Ingelheim with companion-animal vaccines, therapeutics and care products across dermatology, anti-infectives and nutraceuticals — a broad incumbent overlapping JM Sante's portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
JM Sante Pharma social profiles
Digital presenceJM Sante Pharma compliance and trust
Trust signalCompliance3 records
JM Sante Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
JM Sante Pharma leadership team
Management profileNumber of profiles
Profiles1 record
JM Sante Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JM Sante Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JM Sante Pharma
What does JM Sante Pharma do?
JM Sante Pharma develops, manufactures, and sells a portfolio of veterinary pharmaceutical and care products for companion animals (dogs and cats) under multiple branded product lines. Offerings include wound care products (hydrocolloid gels, irrigation solutions, antiseptic sprays), skin and coat care (shampoos, emulsions, balms), oral cavity care, joint/kidney/digestive supplements, and natural cosmetic care products. Products are sold primarily through the company's own direct-to-consumer e-commerce store (jmsante.pl) in Poland, with secondary B2B/export distribution to international markets.
Is JM Sante Pharma a public or private company?
JM Sante Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was JM Sante Pharma founded?
JM Sante Pharma was founded in -1. It employs 11 to 50 people.
Where is JM Sante Pharma based?
JM Sante Pharma is headquartered in Sosnowiec, Poland, in the Europe region.
How does JM Sante Pharma make money?
Two revenue lines are on record. Direct E-commerce Sales are the primary driver. The others are B2B/Export Sales.
Who are JM Sante Pharma's main competitors?
Direct peers on record are Virbac, Ceva Santé Animale, Calier (Grupo Indukern), Vetoquinol and Dechra Pharmaceuticals. Regional players are Veto-Pharma (Hungary) and ScanVet (Poland). Broad incumbents are Elanco Animal Health, Zoetis and Boehringer Ingelheim Animal Health.
Does JM Sante Pharma have an API?
No public API is recorded for JM Sante Pharma.
What industry is JM Sante Pharma in?
JM Sante Pharma's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals, with a secondary code of HLAMAIAD, Compounding Pharmacies (Veterinary). Its NAICS code is 325412 and its SIC code is 2834.